Executive Committee
David Adams
(he/him)
David Adams is a Senior Group Leader at the Wellcome Sanger Institute with an interest in functional genomics, genetic screens, cancer models and drug discovery. He is also co-chair of Cell and Molecular Biology at the Cambridge Cancer Centre and of the GenoMEL (the Genetics of Melanoma) Consortium.
Doug Fowler
(he/him)
Dr. Fowler is a leader in high-throughput, sequencing-based assays, and his lab has deep expertise in large-scale experimental approaches and computational analyses. He is now working to understand the effects of the millions of variants found in a typical human genome. Dr. Fowler is an Associate Professor of Genome Sciences and an Adjunct Associate Professor of Bioengineering at the University of Washington.
Irene Gallego Romero (she/her)
Dr. Gallego Romero is a group leader in human genomics and evolution at the University of Melbourne. Her work focuses on genetic differences between human populations, personalized medicine, and global health equity. Irene’s lab combines functional genomics with the versatility of induced pluripotent stem cells to address questions about the mechanisms of evolutionary adaptation in humans.
Anna Gloyn
(she/her)
Anna Gloyn is currently Professor of Pediatrics and by Courtesy Genetics at Stanford University. The consistent focus of her research has been using naturally occurring mutations in humans as tools to identify critical regulatory pathways and insights into normal physiology and to translate this information into improvements in clinical care.
Matthew Hurles
(he/him)
Matt Hurles is a human geneticist focused on understanding the genetic architecture of severe developmental disorders. His lab combines large-scale genetic analysis of patient cohorts with modelling of pathogenic mutations in experimental model systems. Matt is passionate about sharing data to benefit patients and their families.
Debora Marks
(she/her)
Debora is a mathematician and computational biologist with a track record of using novel algorithms and statistics to successfully address unsolved biological problems. Her lab at Harvard is interested in developing methods in deep learning to address a wide range of biological challenges including predicting the effects of genetic variation and sequence design for biosynthetic applications.
Frederick (Fritz) Roth (he/him)
Frederick (Fritz) Roth (U Toronto, Sinai Health and University of Pittsburgh) trained in physics and biology (UC Berkeley) and biophysics (Harvard). After early work on functional and motif enrichment in transcriptomic data, his team maps genetic and protein interactions and identifies damaging human variants.
JT Neal
(he/him)
J.T. is a Merkin Institute Fellow and Senior Group Leader at the Broad Institute of MIT & Harvard. His lab develops, scales and applies cutting-edge genomic and cellular approaches to characterize the effects of human genetic variation and cellular heterogeneity in cancer and other diseases.
Alan Rubin
(he/him)
Dr. Rubin is a computational biologist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. Alan’s work focuses on developing new tools and approaches to analyze and interpret high-throughput genomics data.
Lea Starita
(she/her)
Dr. Starita is an Assistant Professor. in the Department of Genome Sciences at the University of Washington and the Co-director of Brotman Baty Advanced Technology Lab. She earned her Ph.D. from Harvard Medical School before coming to the University of Washington to train in functional genomics with Stan Fields and Jay Shendure.
Administrative Support
Lara Muffley (she/her)-
Program Manager
muffley [@] uw.edu
Alex Hopkins (he/him)-
Program Operations Specialist
hopkins3 [@] uw.edu
Previous Members
Gladys Fongong (she/her)
Program Operations Specialist
Beth Lowry (she/her)
Administrative Specialist
William C Hahn (he/him)
Executive Committee Member (Broad Institute)